Skip to Content
Merck
  • Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors.

Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors.

Nature communications (2018-09-01)
Fresia Pareja, Alissa H Brandes, Thais Basili, Pier Selenica, Felipe C Geyer, Dan Fan, Arnaud Da Cruz Paula, Rahul Kumar, David N Brown, Rodrigo Gularte-Mérida, Barbara Alemar, Rui Bi, Raymond S Lim, Ino de Bruijn, Sho Fujisawa, Rui Gardner, Elvin Feng, Anqi Li, Edaise M da Silva, John R Lozada, Pedro Blecua, Leona Cohen-Gould, Achim A Jungbluth, Emad A Rakha, Ian O Ellis, Maria I A Edelweiss, Juan Palazzo, Larry Norton, Travis Hollmann, Marcia Edelweiss, Brian P Rubin, Britta Weigelt, Jorge S Reis-Filho
ABSTRACT

Granular cell tumors (GCTs) are rare tumors that can arise in multiple anatomical locations, and are characterized by abundant intracytoplasmic granules. The genetic drivers of GCTs are currently unknown. Here, we apply whole-exome sequencing and targeted sequencing analysis to reveal mutually exclusive, clonal, inactivating somatic mutations in the endosomal pH regulators ATP6AP1 or ATP6AP2 in 72% of GCTs. Silencing of these genes in vitro results in impaired vesicle acidification, redistribution of endosomal compartments, and accumulation of intracytoplasmic granules, recapitulating the cardinal phenotypic characteristics of GCTs and providing a novel genotypic-phenotypic correlation. In addition, depletion of ATP6AP1 or ATP6AP2 results in the acquisition of oncogenic properties. Our results demonstrate that inactivating mutations of ATP6AP1 and ATP6AP2 are likely oncogenic drivers of GCTs and underpin the genesis of the intracytoplasmic granules that characterize them, providing a genetic link between endosomal pH regulation and tumorigenesis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
PP2, ≥98% (HPLC)